Fleury S.A.
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and cli… Read more
Market Cap & Net Worth: Fleury S.A. (FLRY3)
Fleury S.A. (SA:FLRY3) has a market capitalization of $1.39 Billion (R$8.44 Billion) as of March 18, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #9923 globally and #79 in its home market, demonstrating a -2.70% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fleury S.A.'s stock price R$15.49 by its total outstanding shares 545015471 (545.02 Million).
Fleury S.A. Market Cap History: 2015 to 2026
Fleury S.A.'s market capitalization history from 2015 to 2026. Data shows growth from $425.14 Million to $1.39 Billion (11.90% CAGR).
Index Memberships
Fleury S.A. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
BOVESPA Index
BVSP
|
$130.67 Billion | 0.41% | #25 of 80 |
|
SAO PAULO SE IGCX INDEX
IGCX
|
$194.24 Billion | 0.28% | #36 of 155 |
Weight: Fleury S.A.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Fleury S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fleury S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.16x
Fleury S.A.'s market cap is 0.16 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
2.19x
Fleury S.A.'s market cap is 2.19 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.10 Billion | $2.10 Billion | $228.75 Million | 0.53x | 4.82x |
| 2017 | $1.89 Billion | $2.38 Billion | $320.62 Million | 0.79x | 5.89x |
| 2018 | $1.31 Billion | $2.66 Billion | $331.58 Million | 0.49x | 3.94x |
| 2019 | $2.13 Billion | $2.91 Billion | $312.32 Million | 0.73x | 6.81x |
| 2020 | $1.93 Billion | $2.97 Billion | $256.96 Million | 0.65x | 7.52x |
| 2021 | $1.34 Billion | $3.87 Billion | $349.93 Million | 0.35x | 3.83x |
| 2022 | $1.24 Billion | $4.46 Billion | $307.91 Million | 0.28x | 4.04x |
| 2023 | $1.56 Billion | $6.47 Billion | $423.76 Million | 0.24x | 3.69x |
| 2024 | $1.08 Billion | $7.68 Billion | $616.17 Million | 0.14x | 1.75x |
| 2025 | $1.34 Billion | $8.29 Billion | $612.83 Million | 0.16x | 2.19x |
Competitor Companies of FLRY3 by Market Capitalization
Companies near Fleury S.A. in the global market cap rankings as of March 18, 2026.
Key companies related to Fleury S.A. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Fleury S.A. Historical Marketcap From 2015 to 2026
Between 2015 and today, Fleury S.A.'s market cap moved from $425.14 Million to $ 1.39 Billion, with a yearly change of 11.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$1.39 Billion | +3.27% |
| 2025 | R$1.34 Billion | +24.28% |
| 2024 | R$1.08 Billion | -30.96% |
| 2023 | R$1.56 Billion | +25.84% |
| 2022 | R$1.24 Billion | -7.25% |
| 2021 | R$1.34 Billion | -30.61% |
| 2020 | R$1.93 Billion | -9.16% |
| 2019 | R$2.13 Billion | +62.73% |
| 2018 | R$1.31 Billion | -30.75% |
| 2017 | R$1.89 Billion | +71.14% |
| 2016 | R$1.10 Billion | +159.38% |
| 2015 | R$425.14 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Fleury S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.39 Billion USD |
| MoneyControl | $1.39 Billion USD |
| MarketWatch | $1.39 Billion USD |
| marketcap.company | $1.39 Billion USD |
| Reuters | $1.39 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.